While no prediction is guaranteed, the future of T&E looks promising. Expect breakthroughs in AI, system integration, ...

Therapeutics (NASDAQ: ESPR) fell 5.8% after the company provided an update on its expected operating expenses for the fiscal ...

Wall Street analysts raised their price targets on SLM Corp (NASDAQ:SLM) after the company released its fourth-quarter print ...

(Reuters) - AbbVie lowered its 2024 adjusted profit forecast on Monday as the drugmaker incurred $1.6 billion in acquisition expenses related to milestone payments as well as research-and ...

The updated financial guidance indicates that the company anticipates operating expenses to total between $215 million and $235 million for the year. This forecast represents a significant ...